Shortly after securing an FDA clearance this year for its transvaginal robotic surgery system, Memic Innovative Surgery has now raised $96 million to kickstart its commercial efforts and scale up manufacturing in the U.S. and abroad.
Apr 5, 2021 3:30pm Inscripta’s latest funding round will support the development and distribution of its Onyx benchtop platform, which uses CRISPR gene editing technology for fully automated genomic engineering. (AstraZeneca)
Inscripta just got another step closer to achieving its mission of bringing CRISPR gene editing technology to the scientific masses.
The genomic engineering company, a member of Fierce Medtech’s 2019 Fierce 15, recently closed a series E funding round totaling $150 million. The investment was led by Fidelity Management and Research Company and funds and accounts managed by T. Rowe Price Associates.
Upon the close of a $125 million series D round in December 2019, Inscripta calculated its total amount of funds raised since its 2015 founding at $259.5 million. With the latest influx of funds and an extension of the series D in November 2020, that total now clocks in at well over $450 million.
Apr 5, 2021 11:43am Backed by BARDA and the Department of Defense, Ortho Clinical Diagnostics is planning to provide up to 6.7 million COVID tests per month by April 2022. (Getty Images)(Circle Creative Studio/iStock/Getty Images Plus/Getty Images)
Vaccination rates may be steadily climbing across the country, but companies hope COVID-19 testing won t slow down any time soon. In fact, manufacturers are now ramping up production of antigen and antibody tests, with Ortho Clinical Diagnostics, for one, expecting to triple its output within the next year.
Ortho’s increased production will be backed by a new contract with the U.S. government s Biomedical Advanced Research and Development Authority, known as BARDA, and a COVID-19 acquisition task force set up by the Air Force.
[Startup Bharat] With generic drugs, Ahmedabad-based Medkart aims to lower your medical bills
Ahmedabad-based startup Medkart Pharmacy is a drugstore chain that guides patients to buy quality generic alternatives and save on their medical bills.
0 claps
Share on
A move to help people lower their medical bills by enabling access to generic versions of costly branded drugs led Ankur Agarwal to establish Medkart Pharmacy in Ahmedabad with Parasharan Chari and Parthiv Shah.
The medtech startup was set up in September 2014 to raise awareness about cheap generic drugs certified by the World Health Organization’s Good Medical Practices (WHO GMP) and make them available to patients.
Mar 16, 2021 12:22pm XPrize previously launched competitions for the use of artificial intelligence models against the pandemic as well as a million-dollar challenge to design a next-generation face mask. (Getty Images/Naeblys)
Nine teams have been selected as the winners of XPrize’s $6 million COVID-19 testing competition, with the goal of providing affordable and accurate diagnostics to help ensure the safety of everyday activities.
Five grand prize winners brought forward unique antigen- and RNA-based tests that aim to meet the public’s high demand for diagnostics while also helping prevent future supply chain issues.
A separate “open innovation track” selected four participants that employed screening technologies outside of typical tests such as a panel to detect changes in a person’s sense of smell and breath analysis machines to detect viral infections.